Product

Echinocandin

Aliases

Anidulafungin, Caspofungin, Micafungin

Name

Micafungin

INN Name

anidulafungin

FDA Approved

Yes

1 clinical trial

2 organizations

3 indications

2 documents

Indication

Indication

Indication

Clinical trial

A Phase 3, Multicenter, Prospective, Randomized, Double-blind Study of Two Treatment Regimens for Candidemia and/or Invasive Candidiasis: Intravenous Echinocandin Followed by Oral Ibrexafungerp Versus Intravenous Echinocandin Followed by Oral Fluconazole (MARIO)

Status: , Estimated PCD: 2024-06-01

Document

DailyMed Label: Micafungin

Organization

Par Pharmaceutical, Inc.

Document

DailyMed Label: ERAXIS

Organization